A trial of community wide treatment to reduce scabies in a village setting in northern India

Phase 4

Recruiting

• Conditions: Scabies; Skin - Dermatological conditions; Infection - Other infectious diseases

• Registration Number: ACTRN12619001712190
• Lead Sponsor: The Nossal Institute for Global Health (University of Melbourne)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-12-05
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2200

Inclusion Criteria

All residents of the study area are eligible to participate in this study

Exclusion Criteria

As this is a mass drug administration program, all residents of the selected area are eligible for inclusion in this study. However, the exclusion criteria for drug administration are:
- Allergy to any of the components of the allocated drug regimen
- Currently on or has taken ivermectin in the previous 7 days
- Clinical diagnosis of crusted scabies (will be referred for specialist assessment)

These criteria exclude individuals from study drug administration but they remain eligible for inclusion in the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified